We believe people should have the power to shape their own health.
Hormones have a powerful impact on our bodies, but we have very little personal insight into how they work. Eli‘s vision to make health information accessible to women at home. Our products are evidence-based, created in collaboration with medical experts and easy to use. Eli empowers women in their health journey, at every stage.
For us, Eli is personal.
Our co-founder, Marina, wanted a non-hormonal, non-invasive form of contraception, but couldn’t find one. This missing solution impacted her directly and showed her that without contraceptive freedom, women lack control over their own health. As she spoke to other women, she learned how a lack of hormonal data impacted them in their day-to-day lives and wellbeing. These problems ranged from cumbersome alternatives for tracking fertility, to zero solutions for perimenopause and endocrine conditions, to no clear way to track general hormonal health.
Eli was created to empower women. To offer greater control over personal health and life choices. And to provide access to evidence-based hormone insights, grounded in real-time data.
Meet the humans behind Eli.
We are a group of experienced scientists, engineers, and founders working together with boldness, integrity and trust to solve a problem that impacts women across all stages of life. We are passionate about women’s health and working to shift the paradigm to put women’s health in their own hands.
Marina Pavlovic Rivas
Co-founder & CEO
Marina is a repeat founder passionate about empowering people with information. This passion is the common driver underlying her diverse background that blends data science, media, and women's health. Marina founded Eli to create a solution that she personally needed. She founded the company after the acquisition of her previous venture, which developed machine learning solutions for editorial and creative divisions of large media groups in North America and Europe. Before this, Marina led D2C efforts for a variety of startups. She has a Masters in Data Science and a Bachelor in Communications. Her work to close gender gaps also led her to create a community of over a thousand female data scientists.
Co-founder & CTO
Thomas is a repeat founder with an interdisciplinary background in mechanical engineering and physics. He sees technology as a way to solve the greatest problems affecting people. His long-standing passion for hardware led him to build from the ground up and manufacture impactful products through his previous ventures, where he developed solid operational expertise. Thomas worked as an engineer in highly regulated and technologically complex fields, including diagnostics, robotics, and aerospace. He holds a Bachelor in Mechanical Engineering, and a Diploma in Physics focused on sensor design, which he completed in France before immigrating to North America ten years ago.
Chief of Staff
Before Eli, Zoya was the founder and CEO of CORE Diagnostics, a genetics company that brought advanced testing to self-pay markets. The company served over one million patients, expanded to over a dozen countries, developed over a thousand lab tests, and scaled from two to five hundred people. She also created a one-of-a-kind work culture of complete transparency and no hierarchy. Zoya brings with her experience of diverse healthcare systems including B2B experience across channels and partnerships. Before starting CORE at 23 years old, she worked at Google and completed a Bachelor in Sociology.
Head of Growth & Partnerships
Mindy’s experience blends B2B and B2C sales, marketing, and partnerships in high-growth environments as well as building and executing global go-to-market strategies. Before Eli, Mindy was the first employee of a B2B SaaS startup, helping build it from scratch and growing it to the point of acquisition for $65M. She drove global client acquisition and built additional revenue streams via partnerships as part of the senior leadership team. In addition to advising startups, Mindy built her own D2C brand. She holds a Masters from New York University.
After completing his education in Chemical Engineering, James fell in love with assay development. Before Eli, he pushed the boundaries of assay development while managing assay R&D and manufacturing at Vessel, a D2C at-home testing company based in San Diego. Under his lead, James’ former team put over 3 million LFA tests in the hands of consumers. Prior to Vessel, James created in vitro assays to support vaccine development and contributed to vaccine formulation and production in the US. He loves to learn, teach, and create wherever he goes.
Dr. Emilie Heckel
Senior R&D Scientist
Emilie brings more than 15 years of experience in Molecular Biology. During her work in the industry and various research institutes, she developed analytical biochemistry assays and conducted meticulous research to answer multifaceted questions. She has led teams of scientists and managed laboratory biosensing platforms. Emilie has over two dozen peer-reviewed publications in top journals. She holds two postdoctoral degrees, a PhD in Developmental Biology, a Master's in Infectiology, and a Bachelor in Life Sciences. Outside of work, Emilie is also an award-winning athlete.
Sarah holds a Master of Public Health in Health Management from Harvard. Her public health lens opens up a wide range of perspectives that directly influence Eli’s team, users, and product development. Her experience also includes strategy and management consulting for Accenture. Before her work as a consultant, Sarah completed a Bachelor of Commerce in Business Technology Management.
Celine is an interdisciplinary scientist who has combined her interests in biology and engineering to tackle problems in the health space. Before Eli, she worked at a medical device startup on product development, clinical research, human factor testing, and regulatory processes, which led to FDA and CE mark approvals. Celine holds a Master of Applied Sciences in Biomedical Engineering.
Software & Data Science Lead
Vincent has over ten years of hands-on experience in machine learning and software development. He has developed more than a dozen software products, many of which had machine learning at their core, and coached software teams towards agility and organizational effectiveness. Vincent holds a Master’s in Computer Science specializing in AI, a Bachelor in Software Engineering, and an MBA from McGill.
Claudia is a four-time founder. Across her ventures, she has deployed her engineering background to create social impact and advance gender equality. In addition, she is a Co-founder of the Women in Tech Manifesto, a call for parity in the STEM industry. She has raised over $10M in non-dilutive funding for various organizations. She holds a Bachelor’s in Mechanical Engineering and a Master's in Management and Engineering.
Before Eli, Megan worked in R&D and QA Engineering at a medical device startup where she gained experience in product design and regulatory compliance. She participated in developing over ten medical devices, hardware, and software products. She also co-founded McGill's first-ever biomedical engineering design team. She holds a Bachelor’s in Bioengineering and Biomedical Engineering.
Nadine has a demonstrated history of working in the medical practice industry, specializing in biochemical methods, immunochemistry, and biosensor development. She combines her medical field and academic background for medical device development. Nadine holds a Bachelor’s in Biochemistry and a Master’s in Biomedical Engineering, during which she took part in international competitions on sensors for health.
Lucie enjoys designing better products with meaning and reflection. As an industrial designer, she loves to imagine products that respect environmental, social, economic, and ethical factors. Before Eli, Lucie worked on medical devices and products that seamlessly combined hardware and software to improve the health outcomes of users and help them reduce their environmental footprint.
Seasy is a researcher, developer, and designer passionate about making both healthcare and data more accessible. Before Eli, she conducted research on the impact of sex hormones and the correlations of these hormones across blood and saliva. Previously, she worked in front-end development at a data science startup. She holds a Master of Sciences in Physiology and a Bachelor of Computational Biology.
Puloma is a student researcher focused on creating a lasting impact on people’s health. Before Eli, she conducted independent research to create a self-dissolving plastic water bottle. Previously, she conducted computational research for the Broad Institute of MIT and Harvard in their epigenomics and cancer labs. She is a Meinig Family National Scholar at Cornell University and is pursuing a Bachelor’s in Biomedical Engineering.
Eli is backed by industry leaders, but not just any leaders.
Our advisors are a select group of individuals who share our goals. They’re with us every step of the way as we change the world of women’s health.
Ruby Gadelrab Tudor
Ruby is a seasoned commercial health executive with over 20 years of experience in biotech, healthcare and healthtech industries. In the past, she served as the VP of Commercial Marketing at 23andMe, the pioneering DTC healthcare company, where she built non-consumer business models. She is currently the CEO and Co-founder of MDisrupt, a marketplace for connecting clinicians and scientists with digital health companies. In addition, she consults for companies in the genetics, healthcare and healthtech spaces on commercialization strategies. Ruby’s background includes senior executive roles developing B2B and B2C commercial strategies at high profile companies including Life Technologies, Affymetrix, and InVitae. She holds a Bachelor of Molecular Biology from UCL.
Dr. Rhonda Zwingerman
Dr. Zwingerman is a physician and reproductive endocrinology and infertility (REI) specialist who recently co-founded Twig Fertility. Having gone through IVF herself, Dr. Zwingerman is committed to modernizing fertility care by using best-in-class technologies and building a clinic that provides people with comprehensive and compassionate fertility care. Dr. Zwingerman sits on the REI and Genetics Committees of the Society of Obstetricians and Gynecologists of Canada (SOGC) and has co-authored the Canadian guidelines on preimplantation genetic testing. She has completed her Residency in Obstetrics & Gynecology from the University of Alberta, a Master’s in Health Policy, Management & Evaluation from University of Toronto and a Clinical Fellowship in Gynecologic Reproductive Endocrinology & Infertility from the University of Toronto.
Steve Arless is one of Canada’s leading entrepreneurs in the biomedical technology industry. He directed and developed several highly regulated medical device companies from inception through major financing and public stock offering, advancing new medical devices from R&D to commercialization and global sales. He has served as CEO for a number of companies, most notably CryoCath Technologies (sold to Medtronic for $400 million CAD), Resonant Medical (sold to Elekta AB for $30 million), and CardioInsight (also sold to Medtronic for $100 million USD). With a passion for helping entrepreneurs flourish, Steve serves as EIR at MedTech accelerator Centech. He is also a Professor of Practice in the Faculty of Medicine at McGill University. In 2019, Steve co-founded and took the position as CEO of ViTAA Medical Solutions, a healthcare AI company.
Devon C Campbell
Devon has expertise at the intersection of engineering, biology, and design. He has 22 years of experience leading the development of innovative, commercially successful medical devices, in vitro diagnostics, and companion diagnostics. In the past, he has been a product development executive at a number of organizations including startups and global healthcare companies. Devon’s background includes contributing to the Ventana acquisition by Roche for $3.4B, Novartis’ Genoptix acquisition in 2011 for $470M and Vivacta in 2012 for $90M. He was also part of the team that led to the successful IPO of Quanterix for $73.3M. He holds a Master and Bachelor of Science in Mechanical Engineering from the University of Arizona, and an Advanced Executive Certificate in Management, Innovation & Technology from MIT.